寶通科技(300031.SZ):第二期員工持股計劃完成股份協議轉讓過户
格隆匯3月20日丨寶通科技(300031.SZ)公佈,公司於2020年3月19日收到持股5%以上股東樟樹市牛曼投資管理中心(有限合夥)(“牛曼投資”)的通知,牛曼投資向公司第二期員工持股計劃協議轉讓的公司股份已在中國證券登記結算有限責任公司深圳分公司辦理完成過户登記手續。
此次協議轉讓完成後,牛曼投資持有股份1983.84萬股,佔總股本比例4.99999%,佔總股本比例(不含回購股份)5.15143%;公司第二期員工持股計劃持有股份1984.52萬股,佔總股本比例5.00172%,佔總股本比例(不含回購股份)5.15321%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.